Bariatric surgery: A promising solution for nonalcoholic steatohepatitis in the very obese

Journal of Clinical Gastroenterology

Volumn 40, Issue SUPPL. 1, 2006, Pages

  Shaffer, Eldon A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bariatric surgery; Metabolic syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Obesity; Weight loss

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTILIPEMIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; FAT; FATTY ACID; INSULIN; LIPID; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID; VERY LOW DENSITY LIPOPROTEIN;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; EPIDEMIOLOGICAL DATA; GASTRIC BANDING; GASTROINTESTINAL SURGERY; HEPATITIS; HEREDITY; HUMAN; INSULIN RESISTANCE; JEJUNOSTOMY; LIPID PEROXIDATION; LIPOLYSIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOW CALORY DIET; MALABSORPTION; META ANALYSIS; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; WEIGHT REDUCTION;

BARIATRIC SURGERY; FATTY LIVER; HUMANS; OBESITY, MORBID; WEIGHT LOSS;

EID: 33748205849     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000168649.79034.2e     Document Type: Conference Paper

References (59)

1. Manson JE, Skerrett PJ, Greenland P, et al. Escalating pandemics of obesity and sedentary lifestyle: a call to action for clinicians. Arch Intern Med. 2004;164:249-258.
2. Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab. 2004;89:2522.
3. American Gastroenterological Association Clinical Practice Committee. AGATechnical Review on obesity. Gastroenterology. 2002;123:882-932.
4. National Institutes' of Health, National Heart, Lung and Blood Institute. Clinical Guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res. 1998;6(suppl 2):51-209.
5. World Health Organization Consultation on Obesity. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, June 3-5, 1997. Geneva. World Health Organization, Division of Noncommunicable Disease Programme of Nutrition Family and Reproductive Health, 1998.
6. Kaplan L. Body weight regulation and obesity. J Gastrointest Surg. 2003;7:443-451.
7. Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. Obes Rev. 2001;2:219-229.
8. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
9. St-Onge MP, Janssen I, Hemsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese normal-weight individual. Diabetes Care. 2004;27:2222-2228.
10. Kline S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:249-257.
11. Carr DB, Ultzschneider KM, Hall RL, et al. Intra-abdominal fat is a major determinant of the national cholesterol education program adult panel III criteria for the metabolic syndrome. Diabetes Care. 2004;53:2087-2094.
12. Manson JE, Skerrett PJ, Greenland P, et al. The escalating pandemics of obesity and sedentary life style. Arch Intern Med. 2004;164:249-258.
13. Flegal AM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
14. Katzmarzyk PT. The Canadian obesity epidemic, 1985-1998. Can Med Assoc J. 2002;166:1039-1040.
15. Birmingham CL, Muller JL, Palepu A, et al. The cost of obesity in Canada. Can Med Assoc J. 1999;160:483-488.
16. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med. 2003;163:2146-2148.
17. Flegal KM, Carroll MD, Kucmarski RJ, et al. Overweight and obesity in the United States: prevalence and tends, 1960-1994. Int J Obes. 1998;22:39-47.
18. Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends amongst U.S. children and adolescence, 1999-2000. JAMA. 2002;288:1728-1732.
19. Shaffer EA. Nonalcoholic steoatohepatitis: more than just being fat. Can J Gastroenterol. 2002;16:318-321.
20. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;34:1221-1231.
21. Elba LM, Lindor K. Non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2003;17:977-986.
22. Festi E, Colecchia A, Sacco T, et al. Hepatic steatosis in obese patients: clinical aspects and prognostics significance. Obes Rev. 2004;5:27-42.
23. Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis. 2004;8:501-519.
24. Haynes P, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease in individuals with severe obesity. Clin Liver Dis. 2004;8:535-547.
25. Garcia-Monson C, Martin-Perez E, Iacono O, et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol. 2000;33:716-724.
26. Beymer C, Kowdley KV, Larson A, et al. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg. 2003;138:1240-1244.
27. Spaulding L, Trainer T, Janiec D. Prevalence of nonalcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass. Obes Surg. 2003;13:347-349.
28. Hui JM, Kench JG, Chitturi S, et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology. 2003;38:420-427.
29. Ioannou GN, Weiss NS, Kowdley KV, et al. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology. 2003;125:1053-1056.
30. Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis. 2004;8:549-558.
31. Malnick SDH, Beergabel M, Knobler H. Non-alcoholic fatty liver: a common manifestation of a metabolic disorder. Q J Med. 2003;96:699-709.
32. Day CO, James OFW. Steatohepatitis: a tale of two "hits." Gastroenterology. 1998;114:842-845.
33. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steoatohepatitis. N Engl J Med. 2000;343:1467-1473.
34. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139:933-949.
35. Capron JP, Delamarre J, Dupas JL, et al. Fasting in obesity; another cause of liver injury with alcoholic hyaline? Dig Dis Sci. 1982;27:265-268.
36. Andersen T, Gluud C, Franzmann MB, et al. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol. 1991;12:224-226.
37. Hamilton DL. Vest TK. Brown BS, et al. Liver injury with alcoholic-like hyalin after gastroplasty for morbid obesity. Gastroenterology. 1983;85:722-726.
38. Requarth JA, Burchard KW, Colacchio TA, et al. Long-term morbidity following jejuno ileal bypass: the continuing potential need for surgical reversal. Arch Surg. 1995;130:318-325.
39. Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect drastic weight loss after gastroplasty. International Journal of Obesity. 1998;22:222-226.
40. Wang RT, Koretz RL, Yee HF. Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review. Am J Med. 2003;115:5554-5559.
41. Scott HW, Law DH, Sandstead HH, et al. Jejuno-ileal shunts in surgical treatment of morbid obesity. Ann Surg. 1970;171:770-782.
42. National Institutes of Health Consensus Development Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956-961.
43. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737.
44. Mason EE. Vertical banded gastroplasty for obesity. Arch Surg. 1982;117:701-706.
45. Belachew M, Legrand M, Vincent V, et al. Laparoscopic adjustable gastric banding. World J Surg. 1998;22:955-963.
46. DeMaria EJ, Sugerman HJ, Kellum JM. High failure rate following laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg. 2001;233:809-818.
47. MacLean LD, Rhode BM, Sampalis J, et al. Results of the surgical treatment of obesity. Am J Surg. 1993;165:155-160.
48. Howard L, Malone M, Michalek A, et al. Gastric bypass and vertical banded gastroplasty- a prospective randomized comparison and 5-year follow-up. Obes Surg. 1995;5:55-60.
49. Lee W-J, Huang M-T, Wang W, et al. Effects of obesity surgery on the metabolic syndrome. Arch Surg. 2004;139:1088-1092.
50. Christo NV, Sampalis JS, Liberman M, et al. Surgery decreases long term mortality, morbidity and health care use in morbidly obese patients. Ann Surg. 2004;240:416-424.
51. Ing TH, Crebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics. 2004;114:217-223.
52. Sugerman HJ, DeMarie EJ, Kellum JM, et al. Effects of bariatric surgery in older patients. Ann Surg. 2004;204:243-247.
53. Dresel A, Kuhn JA, McCarty TM. Laparoscopic Roux-en-Y gastric bypass in the morbidly obese and super morbidly obese patients. Am J Surg. 2004;187:230-237.
54. Livingston EH. Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surg. 2004;188:105-110.
55. Steinberg R. Surgery for severe obesity. N Engl J Med. 2004;250:1075-1079.
56. NHS Centre for Reviews and Dissemination. University of York, York, U.K: the prevention and treatment of obesity (provisional record). Eff Health Care. 1997;3:1-12.
57. Colquitt J, Clegg A, Sidhu M, et al. Surgery for morbid obesity [Review]. The Cochrane Database of Systemic Reviews, vol. 3. 2004 http://80-gateway2. ovid.com.ezproxy.lib.ucalgary.ca:2048/ovidweb.cgi.
58. Dixon JB, Bhathal PS, Hughes NR, et al. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology. 2004;39:1637-1654.
59. Solga SF, Alkhuraishe A, Clark JM, et al. Gastic bypass surgery markedly improves liver histology in patients with nonalcoholic steatohepatitis [Abstract]. Gastroenterology. 2003;124(suppl 1):239.